Perseveration in Behavioral Neurology
Neurol 37:1736-1741, Sandson,J.&Albert,M.L., 1987
Limb Dystonia in Progressive Supranuclear Palsy
Neurol 37:1546-1549, Rafal,R.D.&Friedman,J.H., 1987
Extrapyramidal Disturbances Caused by Inappropriate Prescribing
BMJ 295:30-31, Pall,H.S.&Williams,A.C., 1987
Flunarizine- & -Cinnarizine-Induced Extrapyramidal Reactions
Neurol 37:881-884, Micheli,F.,et al, 1987
Aggravation of Parkinson's Disease by Cinnarizine
JNNP 50:804-805, Marti-Masso,J.F.,et al, 1987
Adrenal Grafts for Parkinson's Disease
Letter, NEJM 317:1091-10931987., , 1987
Transplantation in Parkinson's Disease:Two Cases of Adrenal Medullary Grafts to the Putamen
Ann Neurol 22:457-468, Lindvall,O.,et al, 1987
Neural Transplants:Are We Ready
Ann Neurol 22:455-456, Joynt,R.J.&Gash,D.M., 1987
Management of Parkinson's Disease
BMJ 294:1393-1396, Gibberd,F.B., 1987
Parkinson's Disease & Motor Fluctuations:Long-Acting Carbidopa. Levodopa (CR-4-Sinemet)
Neurol 37:875-878, Goetz,C.G.,et al, 1987
Controlled-Release Levodopa/Carbidopa. II. Sinemet CR4 Treatment of Response Fluctuations in Parkinson's Disease
Neurol 37:1607-1612, Cedarbaum,J.M.,et al, 1987
Controlled Release Levodopa-Carbidopa (CR-5) in the Management of Parkinsonian Motor Fluctuations
Arch Neurol 44:1010-1012, Juncos,J.L.,et al, 1987
Dietary Influence on the Antiparkinsonian Response to Levodopa
Arch Neurol 44:1003-1005, Juncos,J.L.,et al, 1987
Plasma Levels of Amino Acids Correlate with Motor Fluctuations in Parkinsonism
Arch Neurol 44:1006-1009, Pincus,J.H.&Barry,K.M., 1987
Dietary Therapy for Motor Fluctuations in Parkinson's Disease
Arch Neurol 44:1119-1121, Kurlan,R., 1987
Pathophysiol Clin Assess of Motor Symptoms in PD, Jankovic in Handbook of Parkinson's Disease, Ed W. C. Koller
New York 1987, p. 118-120, 475-488., Marcel Dekker,Inc., 1987
Parkinson's Disease & Myasthenia Gravis:Adverse Effect of Trihexyphenidyl on Neuromuscular Transmission
Neurol 37:832-833, Ueno,S.,et al, 1987
Parkinson's Disease & Pregnancy
Neurol 37:1245-1249, Golbe,L.I., 1987
Parkinson's Disease & Megacolon:Concentric Hyaline Inclusions (Lewy Bodies) in Enteric Ganglion Cells
Neurol 37:1253-1255, Kupsky,W.J.,et al, 1987
Levodopa Methyl Ester Treatment of Parkinson's Disease
Neurol 37:1242-1245, Juncos,J.L.,et al, 1987
Raised Cerebrospinal-Fluid Copper Concentration in Parkinson's Disease
Lancet 2:238-241, Pall,H.E.,et al, 1987
Giant Middle Cerebral Aneurysm Presenting as Hemiparkinsonism
JNNP 50:1075, Gross,M., 1987
Paraquat & Parkinson's Disease
Neurol 36:1147, Koller,W.C., 1986
Neuropeptides in Neurological Disease
Ann Neurol 20:547-565, Beal,M.F.&Martin,J.B., 1986
Disappearance of Parkinsonian Signs after Spontaneous Vascular"Thalamotomy"
Arch Neurol 43:815-817, Dubois,B.,et al, 1986
Parkinson's Disease
BMJ 293:379-382, Quinn,N.P.&Husain,F.A., 1986
Magnetic Resonance Imaging of the Midbrain in Parkinson's Disease
Ann Neurol 20:744-747, Duguid,J.R.,et al, 1986
Smoking & Parkinson's Disease, Search for a Dose-Response Relationship
Arch Neurol 43:774-778, Golve,L.I.,et al, 1986
Cigarette Smoking & Parkinson's Disease
Neurol 36:1490-1496, Baron,J.A., 1986
Mental Disorders in Parkinson's Disease
RI Med Jour 69:323-326, Rafal,R., 1986
Brain Dopamine Metabolism in Patients with Parkinson's Disease Measured with Positron Emission Tomography
JNNP 49:853-860, Leenders,K.L.,et al, 1986
A Case of Parkinsonism Following Striatal Lacunar Infarction
JNNP 49:1087-1088, Friedman,A.,et al, 1986
Hereditary Dystonia-Parkinsonism Syndrome of Juvenile Onset
Neurol 36:1424-1428, Nygaard,T.C.&Duvoisin,R.C., 1986
Pathologic Correlates of Dementia in Parkinson's Disease
Arch Neurol 43:991-995, Chui,H.C.,et al, 1986
Alzheimer's Disease, Parkinson's Disease, & Motoneurone Disease:Abiotropic Interaction Between Ageing & Environment
Lancet 2:1067-1068, Calne,D.B.,et al, 1986
Metoclopramide-Induced Parkinsonism in Hemodialysis Patients
Arch Int Med 146:2070-2071, Sirota,R.A.,et al, 1986
Locus Ceruleus Lesions & Eosinophilic Inclusions in MPTP-Treated Monkeys
Ann Neurol 20:449-455, Forno,L.S.,et al, 1986
Neural Transplantation:Scientific Gains & Clinical Perspectives
Neurol 36:389-392, Fishman,P.S., 1986
MPTP:A Neurotoxin Relevant to the Pathophysiology of Parkinson's Disease, The 1985 George Cotzias Lecture
Neurol 36:250-258, Snyder,S.H.&D'Amato,R.J., 1986
Parkinsonism, Tardive Dyskinesia, Akathisia, & Depression Induced by Flunarizine
Lancet 1:1303-1304, Chouza,C.,et al, 1986
Subcortical Dementia
BMJ 292:1035-1036, Foster,J.B., 1986
Clinicopath. Conference
Pick's Disease of Brain, with Frontal Lobar Atrophy, Degen of Basal Ganglia, Case 16-1986, NEJM 314:, 101-,1986., 1986
The Clinical Features & Natural History of the Steele-Richardson-Olszewski Syndrome (Prog Supranuclear Palsy)
Neurol 36:1005-1006, Maher,E.R.,et al, 1986
The Neuroleptic Malignant Syndrome:Agent and Host Interaction
Acta Psychiatr Scand 73:337-347, Shaley,A.&Munitz,H., 1986
Initiation of Levodopa Therapy in Parkinsonisn Patients Should be Delayed Until the Advanced Stages of the Disease
Arch Neurol 43:402-407, Melamen,E., 1986
Modification of Parkinson's Disease by Long-Term Levodopa Treatment
Arch Neurol 43:405-407, Markham,C.H.&Diamond,S.G., 1986
Pharmacologic Treatment of Parkinsonian Tremor
Arch Neurol 43:126-127, Koller,W.C., 1986
Painful Parkinson's Disease
Lancet 1:1366-1369, Quinn,N.P.,et al, 1986
Lithium for Painful Dystonia in Parkinson's Disease
Lancet 1:1377, Quinn,N.&Marsden,C.D., 1986
Low-Dose Bromocriptine Therapy in Parkinson's Disease:Double-Blind, Placebo-Controlled Study
Neurol 36:291-293, Staal-Schreinemachers,A.L.,et al, 1986